Healthcare provider profile · identity verified

Elizabeth Blount, M.D.

Family Practice · SILVERTON, OR · NPI 1912921313

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	402	110
Levothyroxine Sodium	Levothyroxine Sodium	293	77
Gabapentin	Gabapentin	206	43
Lisinopril	Lisinopril	169	37
Losartan Potassium	Losartan Potassium	166	50
Amlodipine Besylate	Amlodipine Besylate	154	38
Metformin Hcl Er	Metformin Hcl	144	44
Simvastatin	Simvastatin	142	37
Pantoprazole Sodium	Pantoprazole Sodium	134	37
Duloxetine Hcl	Duloxetine Hcl	120	28
Tamsulosin Hcl	Tamsulosin Hcl	117	30
Metoprolol Succinate	Metoprolol Succinate	115	23
Alendronate Sodium	Alendronate Sodium	111	39
Tramadol Hcl	Tramadol Hcl	107	20
Furosemide	Furosemide	103	32
Omeprazole	Omeprazole	103	33
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	95	19
Eliquis	Apixaban	94	20
Trazodone Hcl	Trazodone Hcl	93	27
Bupropion Xl	Bupropion Hcl	87	21
Hydrochlorothiazide	Hydrochlorothiazide	87	24
Ozempic	Semaglutide	83	16
Alprazolam	Alprazolam	81	21
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	73	20
Potassium Chloride	Potassium Chloride	70	19
Rosuvastatin Calcium	Rosuvastatin Calcium	67	20
Citalopram Hbr	Citalopram Hydrobromide	65	15
Finasteride	Finasteride	63	12
Escitalopram Oxalate	Escitalopram Oxalate	57	13
Famotidine	Famotidine	57	17
Celecoxib	Celecoxib	55	15
Lorazepam	Lorazepam	55	13
Ondansetron Odt	Ondansetron	53	11
Venlafaxine Hcl Er	Venlafaxine Hcl	53	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	49	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	45	14
Pregabalin	Pregabalin	44	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	41	23
Allopurinol	Allopurinol	40	suppressed
Sertraline Hcl	Sertraline Hcl	40	suppressed
Clopidogrel	Clopidogrel Bisulfate	38	suppressed
Ezetimibe	Ezetimibe	37	suppressed
Famciclovir	Famciclovir	36	14
Propranolol Hcl	Propranolol Hcl	36	suppressed
Jardiance	Empagliflozin	35	suppressed
Spironolactone	Spironolactone	35	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	34	suppressed
Clonazepam	Clonazepam	30	suppressed
Methadone Hcl	Methadone Hcl	30	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	30	suppressed
Estradiol	Estradiol	29	12
Metoprolol Tartrate	Metoprolol Tartrate	28	suppressed
Montelukast Sodium	Montelukast Sodium	28	suppressed
Cephalexin	Cephalexin	27	18
Fluticasone Propionate	Fluticasone Propionate	26	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Buspirone Hcl	Buspirone Hcl	25	suppressed
Liothyronine Sodium	Liothyronine Sodium	25	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	24	suppressed
Fluconazole	Fluconazole	24	13
Tolterodine Tartrate Er	Tolterodine Tartrate	24	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	23	17
Breo Ellipta	Fluticasone/Vilanterol	23	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	14
Diazepam	Diazepam	23	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	23	suppressed
Pravastatin Sodium	Pravastatin Sodium	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Metformin Hcl	Metformin Hcl	22	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Meloxicam	Meloxicam	21	suppressed
Donepezil Hcl	Donepezil Hcl	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Ketoconazole	Ketoconazole	20	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	suppressed
Topiramate	Topiramate	20	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	19	suppressed
Glimepiride	Glimepiride	18	suppressed
Sucralfate	Sucralfate	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Atenolol	Atenolol	17	suppressed
Ibandronate Sodium	Ibandronate Sodium	17	suppressed
Prednisone	Prednisone	17	12
Synthroid	Levothyroxine Sodium	17	suppressed
Baclofen	Baclofen	16	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	16	suppressed
Temazepam	Temazepam	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Zaleplon	Zaleplon	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Carvedilol	Carvedilol	15	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Doxepin Hcl	Doxepin Hcl	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Carbamazepine	Carbamazepine	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Ranolazine Er	Ranolazine	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Valsartan	Valsartan	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	11	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed
Xifaxan	Rifaximin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error